What is the issue size of the Encube Ethicals Limited IPO?

The total issue size is ₹3,000.00 crore.

Encube Ethicals Limited IPO — Dates, Price Band, Lot Size, Financials & Prospectus Analysis | Anvest

DRHP Filed — Dates AwaitedMAINBOARDOfficial SEBI Filing

Encube Ethicals Limited

Price Band

—

Total Issue Size

₹3,000 Cr

Bidding Window

—

Market Lot

—

Subscription

—

Issue Timeline & Lifecycle

DRHP Filed

6 Aug 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

DRHP Filed

6 Aug 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

AI Company Profile

AI Snapshot

Encube Ethicals Limited IPO

Founded:1995HQ:803, B Wing, HDIL Kaledonia, Sahar Road, Andheri East, Mumbai City, Mumbai 400 069, Maharashtra, India

What Looks Strong

The offer document states no strength that could be verified.

What to Watch

The offer document states no risk factor that could be verified.

Fundamentals & Key Metrics

Period:FY26

Profitability & Returns

6 items

EBITDA Marginℹ

39.29%

Profit Marginℹ

23.62%

RoNWℹ

22.84%

ROCEℹ

28.47%

Basic EPSℹ

₹14.38

Book Valueℹ

₹62.93

Financial Health & Solvency

4 items

Debt/Equityℹ

0.12x

Net Worthℹ

₹1,912.3 Cr

Total Debtℹ

₹221.7 Cr

Operating Cash Flowℹ

₹303.1 Cr

Financials at a glance

Restated Consolidated

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

7 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

Mehul Madhusudan Shah

61.15%

Frontier Investment Holdings Pte. Ltd.

15.02%

Niti Shah

9.30%

Mansi Harses Kampani

5.08%

Niloni Shah

5.08%

Others

4.37%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

The capital base is disclosed, but the offer is not priced and no complete offered-share count is available yet. A percentage would be speculative at this stage.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Lead book managers

JM Financial Limited, Axis Capital Limited, Kotak Mahindra Capital Company Limited

Registrar to the issue

MUFG Intime India Private Limited

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Industry Avg P/E:37.43x

Swipe left / right to view all valuation metrics→

Company
Lupin Limited	₹2,413.95	20.73x	₹27.96K Cr	₹116.44	₹489.98	26.90%
Zydus Lifesciences Limited	₹1,126.5	22.49x	₹27.15K Cr	₹50.09	₹269.43	19.74%
Listed industry peersDr. Reddy’s Laboratories Limited	₹1,147.6	22.79x	₹33.70K Cr	₹50.35	₹453.98	11.75%
Alembic Pharmaceuticals Limited	₹797.05	23.22x	₹7.34K Cr	₹34.33	₹288.70	12.42%
Aurobindo Pharma Limited	₹1,579.35	26.17x	₹33.65K Cr	₹60.34	₹652.39	9.94%
Gland Pharma Limited	₹2,504.4	40.21x	₹6.43K Cr	₹62.28	₹625.62	10.53%
Glenmark Pharmaceuticals Limited	₹2,233.3	46.30x	₹16.98K Cr	₹48.24	₹372.33	14.07%
Rubicon Research Limited	₹1,492.6	97.49x	₹1.75K Cr	₹15.31	₹77.10	26.97%
OneSource Specialty Pharma Limited	₹1,621.75	—	₹1.42K Cr	₹-6.44	₹508.22	-1.26%

Official Prospectus Filings

Encube Ethicals Limited - DRHP Encube Ethicals Limited- Abridged Prospectus

Type: DRHP · Published: 2026-08-06

Encube Ethicals Limited

Issue Timeline & Lifecycle

What Looks Strong

What to Watch

Profitability & Returns

Financial Health & Solvency

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions